TRGM

 
Common Stock SEC Reporting - Delinquent
Pink No Information
Contact Info
  • 2980 Beverly Glen Circle
  • Los Angeles, CA 90077

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2015 10-K
CIK 0001420030
Fiscal Year End 12/31
OTC Marketplace Pink No Information
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1999
Employees 30 a/o Apr 25, 2016
Company Officers/Contacts
Kim Giffoni CEO
William B. Horne CFO
David Silver Chief Med. Officer
Company Directors
Kerry Weems Chairman
Maurice J. DeWald
Kim Giffoni
David Silver
Thomas Wenkart
Service Providers
Accounting/Auditing Firm
Squar Milner
4100 Newport Place Drive
Third Floor
Newport Beach, CA, 92660
United States
 
Securities Counsel
Perkins Coie LLP
1201 Third Avenue
Suite 4900
Seattle, WA, 98101-3099
United States
 
Investor Relations Firm

Not Available
TRGM Security Details
Share Structure
Market Value1 $227,388 a/o Jun 26, 2017
Authorized Shares 100,000,000 a/o Jun 19, 2017
Outstanding Shares 27,730,227 a/o Jun 19, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
Transfer Online, Inc.
Shareholders
Shareholders of Record 282 a/o Apr 29, 2015
Short Selling Data
Short Interest 0 (-100%)
Nov 30, 2015
Significant Failures to Deliver No

1Market Value calculated only for respective security